Phil Haydon’s Alzheimer’s Research Featured in Tufts Now

GliaCure President Phil Haydon’s research on Alzheimer’s disease is featured in Tufts Now, the online content and information hub for the university community. The article, authored by Bruce Morgan, details the initial resistance by the scientific community to the hypothesis that glia play an active role in brain signaling, Phil’s first discoveries regarding the role of glia in Alzheimer’s disease, and the research that led to the development of GC021109, including the recent clinical trial in mild to moderate patients. The article can be found here.